about
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, ...
Read More
13.74
-1.02
(-6.91%)
617.9K
XNAS Volume
XNAS 28 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Vor Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..